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Abstract  
While spatial dose conformity delivered to a target volume has been pushed to its practical limits with advanced 
treatment planning and delivery, investigations in novel temporal dose delivery  are unfolding new mechanisms. 
Recent advances in ultra-high dose radiotherapy, abbreviated as FLASH,  indicate the potential for reduction in 
healthy tissue damage while preserving tumor control. FLASH therapy relies on very high dose rate of > 40Gy/sec 
with sub-second temporal beam modulation, taking a seemingly opposite direction from the conventional paradigm of 
fractionated therapy. FLASH brings unique challenges to dosimetry, beam control, and verification, as well as 
complexity of radiobiological effective dose through altered tissue response. In this review, we compare the 
dosimetric methods capable of operating under high dose rate environments. Due to excellent dose-rate independence, 
superior spatial (~<1 mm) and temporal (~ns) resolution achievable with Cherenkov and scintillation-based detectors, 
we show that luminescent detectors have a key role to play in the development of FLASH-RT, as the field rapidly 
progresses towards clinical adaptation. Additionally, we show that the unique ability of certain luminescence-based 
methods to provide tumor oxygenation maps in real-time with submillimeter resolution can elucidate the 
radiobiological mechanisms behind the FLASH effect. In particular, such techniques will be crucial for understanding 
the role of oxygen in mediating the FLASH effect. 
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Figure 4 Reprinted from “Bringing FLASH to the Clinic: Treatment Planning Considerations for Ultra high Dose-Rate Proton 
Beams”, Vol 106 / Issue 3, Figure 2A, Copyright (2020), with permission from Elsevier.1 
 
 
Figure 8 a) and b) Reprinted from “Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with 
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1. Introduction:  
 
Figure 1) a) Typical dose-response curves in radiotherapy; maximum tumor control with minimal normal tissue complication is 
desired. b) Over last the few decades this has been possible due to spatial modulation of the beam, leading to an increasing use 
of small fields (<10 mm). Unfortunately, this led to complex dosimetric issues unique to small fields that standard dosimeters 
were not suitable for. The x-axis in the in b) denotes the time-line of major advancements that have happened in the field of 
external beam radiotherapy. Left scale denotes how typical field sizes have varied with these advancements and right scale 
shows the number of peer-reviewed publications per year based on a PubMed search of the phrase “Small Field Dosimetry”. c) 
The effect of ultra-high dose rates on cell survival curves. Data adapted from Hornsey et al1, where decreased cell killing was 
seen in mouse intestine at high dose-rates versus low dose-rates. The decrease in cell-killing was attributed to rapid depletion of 
oxygen, which is required to ‘fix’ DNA damage, at high dose-rates.  
 
Decades of research in radiation therapy has been focused towards increasing the therapeutic ratio2 (Figure 1a), and 
many techniques such as inverse treatment planning optimization, intensity modulated radiation therapy, or on-board 
imaging guidance have achieved this goal primarily via higher spatial modulation of the primary beam (Figure 1b). 
Temporal modulation of dose has also been widely exploited in its relation to repair of sublethal damage and the cell 
cycle, and this has been widely adopted in almost all clinical treatments through fractionated treatment plans.  Yet, the 
role of higher dose-rate effects has been largely undeveloped in clinical treatment3. Interesting early studies4–8 (1960-
1980) had observed peculiar effects of reduced cell killing at ultra-high dose-rates, such as the study by Hornsey et 
al1, who illustrated reduced cell killing in mouse intestine at high dose rates(Figure 1c).  However, a recent study 
(2014) by Favaudon et al9 has sparked explosive interest in ultra-high dose rates again. Contrary to conventional 
radiotherapy techniques, which employ mean dose-rates of ~0.03 Gy/s with doses of ~2 Gy delivered over 10-30 
fractions, the authors used an ultra-high mean-dose rate of 40 Gy/s with total irradiation time <500 ms to achieve an 
improved differential response between tumor and normal tissue. They reported less normal tissue damage with high 
dose-rate irradiation when compared to ‘conventional’ radiotherapy conditions, while observing similar anti-tumor 
response in both modalities. The authors termed this phenomenon as the ‘FLASH’ effect. Multiple groups have now 
replicated the FLASH effect in different murine organs10,11 and in superficial treatments in animal models such as 
mini-pigs, cats12 and zebrafish13. It has been shown that the FLASH effect can be triggered using electrons9,14,15, x-
rays16,17 and protons18,19. Recently, the first human patient was treated with FLASH-RT18, with promising clearance of 
the lymphoma lesion with lower skin toxicity than has been seen in previous irradiations.  The field of FLASH-RT 
has experienced wide interest and growth and could be a critical area of development for better normal tissue sparing 
in radiotherapy.   
 The calibration and quality assurance tools for dosimetry also need to be adapted accordingly to keep up with the 
ever-changing nature of radiation dose delivery Historically, spatial modulation in dose delivery has led to increased 
use of small radiation fields or beamlets for which accurate dosimetric characterization was found to be non-trivial. 
These problems associated with small fields are well documented20. This warranted a need for high-resolution 
detectors which most vendors now typically provide for the measurement of cumulative dose distributions21. With the 
emergence of FLASH-RT and other promising high dose-rate modalities, such as Microbeam Radiation Therapy 
(MRT)22 and Synchrotron stereotactic radiotherapy23, it is expected that new dosimetric challenges will arise. 
Spatiotemporal dosimetry for small radiation beamlets delivered dynamically under high dose-rate conditions can be 
difficult. For successful translation of FLASH-RT to a clinical setting, dosimetry must be performed accurately and 
rigorously keeping in mind limitations of various detectors at high dose-rates and non-standard nature of the various 
FLASH irradiation platforms.  The issue of dosimetric uncertainty in preclinical radiobiological studies and its effect 
on reproducibility and eventual translation to clinics has been highlighted by multiple authors24,25. The National 
Institute of Standards and Technology (NIST) has recommendations regarding accurate measurement and reporting of 
dose in preclinical radiobiological studies26.   In a multi-institution audit of irradiator output25, it was found that only 
one facility was able to deliver a dose within 5% of the prescribed limit; other facilities had errors ranging from 12% 
to 42%. The issue is primarily because of the non-standard nature of irradiation platforms used in pre-clinical studies 
and a lack of protocols and guidance. To tackle this issue, the American Association of Physicists in Medicine 
(AAPM) has initiated Task Group No. 319 “Guidelines for accurate dosimetry in radiation biology experiments''. One 
of the major aims of the task group is to standardize dosimetry and review uncertainties associated with non-clinical 
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units used in preclinical radiobiological studies. 
Therefore, this review is motivated by the need to 
assess the various different uncertainties associated 
with performing accurate dosimetry under FLASH and 
high dose-rate irradiation conditions.  
To this end, dosimetric problems unique to high 
dose-rate environment such as FLASH will be 
identified in this review. Common radiation 
dosimeters based on different physical principles, 
mainly, luminescent, charged based and chemical 
detectors will be discussed in light of the dosimetric 
issues identified earlier. We hypothesize that based on 
the underlying physical mechanisms, luminescent 
based detectors can be used to perform accurate, real-
time dosimetry, with predetermined corrections 
under reference conditions to account for non-ideal 
characteristics (e.g. quenching of scintillator 
response for high LET particles and energy 
dependence of Cherenkov radiation). It can be 
argued that the most important dosimetric aspects 
of FLASH-RT (discussed in detail in section 2) are 
dose-rate independence, spatial resolution, and temporal resolution of a detector. Comparing these three 
characteristics of the detectors, their typical usage, and the underlying physics, it can be predicted that luminescent 
detectors offer unparalleled spatial-temporal resolution and dose-rate independence (Figure 2).  Values in Figure 2 are 
based on typical usage and exceptions to these do exist; these exceptions will be noted, where appropriate, in the text. 
Another purpose of this review is to provide an overview of tools that have been used in high-dose rate conditions. 
Therefore, instances of different dosimetric tools used in FLASH-RT and other high dose-rate modalities will be 
consolidated and summarized. Finally, the mediating role of oxygen tension in FLASH-RT will be discussed briefly.  
The superior ability of luminescent based methods to sense oxygen tension and measure dose and LET 
(simultaneously, specifically for particle therapy) in real-time will be described for its potential in understanding the 
radiobiological mechanisms underlying the protective effect of FLASH on normal tissue. 
 
 
 
2. Dosimetric Aspects of FLASH-RT That Need to be Considered 
 
 
2.1 Dose-Rate Dependency  
 
Figure 2) Spider plot comparing the three different categories of 
detector. The axes denote major dosimetric issues associated with 
FLASH-RT. It can be seen that luminescent detectors can provide ~ns 
time-resolution, with sub-millimeter resolution and dose-rate 
independence up to a dose rate of 105 Gy/s.   
Fig. 3) a) Dose rate schemes in radiation therapy indicating different interpretations of dose-rate. b) Typical 
temporal beam characteristics for conventional (CONV) and FLASH-RT using electrons.  
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It is instructive to first compare temporal structure of FLASH and conventional radiotherapy beams in order to 
understand problems unique to high dose-rate conditions. Typically, radiation sources used in radiotherapy are not 
continuous but rather pulsatile in nature. The repetition rate and duty cycle depend on the type of particle acceleration 
used.  For instance, most clinical linear accelerators (linac) typically have a pulse duration of 3-5 μs with repetition 
rate of ~200-400 Hz. For cyclotron based proton beams, the beam can be considered to be quasi-continuous due to 
short pulse duration and repetition rates on the order of a few nanoseconds. Additionally, modern radiation techniques 
typically deliver dose in fractionated manner over a period of few days. Therefore, dose-rate can be either the defined 
over the course of a whole treatment, one fraction or within a single pulse. The different interpretations of dose-rate 
are illustrated in Figure 3a. Table in Figure 3b presents a side by side comparison of temporal beam characteristics of 
FLASH and CONV radiation therapy; the dose per fraction is denoted as the mean dose-rate, Ḋm. The dose-rate in a 
pulse or the instantaneous dose-rate is denoted as Ḋp, which is the ratio of dose delivered in a pulse (Dp) divided by 
the pulse duration. This is an important distinction because instantaneous dose-rates in conventional radiotherapy can 
be comparable or even higher when compared to the mean dose-rate (Ḋm) of 40 Gy/s used to trigger the FLASH effect 
in current preclinical studies. Note that the conventional beam characteristics are based on typical linac based clinical 
beams and the values for FLASH are based on prototype electron linacs that have been successfully used to elicit the 
FLASH effect27.  Multiple studies have now rigorously explored the beam parameters needed to trigger a reproducible 
FLASH effect and it has been shown that the Ḋp and Dp play a critical role27,28. For FLASH-RT, these quantities can 
be orders of magnitude higher as shown in 3b), leading to issues of saturation, and non-linear response of standard 
dosimeters at large doses.  
 
 
2.2 Spatial Resolution  
 
Many preclinical FLASH studies have been performed on small animal models and tumor volumes. As mentioned 
earlier, performing accurate dosimetry with small beamlets is notoriously difficult. If the size of the sensitive volume 
of the detector is comparable to the radiation field size, dose averaging effects can lead to erroneous measurement of 
absorbed dose and artificial broadening of the field penumbra. Multiple preclinical studies have been performed using 
the experimental Oriatron eRT6- 6MeV and Kinetron 4.5 MeV linear accelerator (PMB-Alcen, Peynier, France). 
Design limitations of these linacs result in only small field openings. Small applicators used to confine the radiation 
field to the organs of interest can also introduce additional complex problems29. Additionally, clinical linacs modified 
to deliver flash dose rates30 tends to utilize significantly shorter source to target distance to further increase the dose 
rate. Close proximity to source renders only small field sizes viable. Varian’s Clinac 21EX was modified by Schüler 
et al30  
 
 
Figure 4) Spatial distribution of dose-rate within a pencil beam scanned proton beam illustrating the role of scatter 
contribution from adjacent spots, which leads to an inhomogeneous distribution of dose-rate. A point detector or an 
imaging array with coarse detector spacing will be unable to measure dose-rate distribution with accuracy. Figure 
adapted from Marlen et al31.  
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and it was found that mean dose-rate of 900 Gy/s was achievable near the transmission ionization chamber in the 
gantry head, where 90% of the field diameter was measured to be ~12 mm. For the beam energy used in the study (20 
MeV), this falls in the realm of small field dosimetry, due to the lateral electronic disequilibrium. While small field 
dosimetry issues are not specific to FLASH, they nonetheless contribute to dosimetric complexity. 
A related issue specific to FLASH is that of spatial averaging of dose-rate. Accurate determination of fully spatially-
resolved dose-rate is critical for FLASH accuracy.  This is even more important currently, since one of the main goals 
is to optimize the beam parameters so that a FLASH effect can be elicited in the clinical setting. A simulation study 
conducted by Marlen et al31 explored the idea of spatial dose-rate distribution within a broad beam and its effect on 
FLASH response. Their study was based on pencil beam scanning with protons, but the results can be generalized to 
other modalities. Large field sizes are obtainable with protons when spot scanning techniques are used. However as 
reported in the study, dose rate in one spot will be affected by the low dose-rate scatter contributed by the adjacent 
spots (shown in Figure 4). They reported that only 40 % of the dose is delivered at FLASH rates for a spot peak dose 
rate at the center of 100 Gy/s. When the peak dose rate is increased to 360Gy/s, the contribution to FLASH dose rates 
increases to 75%.  Rahman et al. also measured, using a scintillating sheet, as much as 41% standard deviation in 
maximum dose rate distribution for spot spacing as large as 10 mm (shown in figure 10 a)32. This will also hold true 
for broad electron beams, synchrotron produced x-ray beams and passively scattered proton beams, where scatter can 
contribute to an inhomogeneous distribution of dose-rates across the irradiated volume. This phenomena was also 
studied by Van de Water et al33 where they investigated the possibility of achieving FLASH dose-rates with 
conventional proton pencil beam scanning and intensity modulated proton therapy techniques. They proposed a new 
metric to quantify spatially varying dose-rate in three dimensions, dose averaged dose-rate (DADR) and dose-
weighted average of instantaneous dose-rate of all spots. It remains to be seen if such a criterion has any potential 
clinical value, but it points towards the need of a high resolution imaging detector. Additionally, as FLASH-RT 
continues to move towards clinical translation, large field sizes will need to be delivered at high dose-rates. Spatial 
distribution of dose and dose-rate can only be reliably measured using imaging techniques or detector arrays. Thus, a 
high resolution detector array with small inter-detector spacing is needed, so that a 2D spatial distribution of dose-rate 
can be measured accurately, avoiding any volume averaging effects. A 3D distribution of dose-rate within patient 
geometry would be the ideal case. 
 
2.3 Time Resolution 
 
Another aspect of dosimetry under FLASH conditions is that of real-time dose monitoring vs passive dose 
monitoring. While dose-rate independence is an important requirement for FLASH-RT, the ability to verify machine 
output, dose delivered per pulse, and dose-rate in real-time is of considerable interest.  For high dose-rates and dose 
per pulse conditions, real-time dose monitoring is non-trivial. Not only dose-rate independent dosimeters are required, 
but dosimeters with a high enough temporal resolution and high bandwidth read-out methods are needed. For 
instance, some excellent dose-rate independent detectors like radiochromic film, alanine and TLD’s etc. can only 
provide passive dose monitoring. Additionally, even though certain dosimeters can provide online dose-monitoring, 
they encounter other issues at ultra-high dose-rates which limits their capability. For example, clinical linear 
accelerators employ a monitor chamber in the gantry head which records machine output in real-time and serves as a 
beam-off signal when the recorded dose matches the required dose. However, most commercial ionization chambers 
start to show saturation or decreased ion-collection efficiency at high dose per pulse conditions rendering online 
monitoring of dose problematic at FLASH dose-rates. It has been shown by Jorge et al34 that despite correcting for 
ion-recombination effects at high doses per pulse, ICs can show deviations up to 15%.  
 
 
  2.4 Dynamic Range 
Dynamic range of a dosimeter is another issue pertinent to dosimetry in FLASH-RT. It has been shown that the 
oxygen depletion effect is highly dependent on the total dose delivered35–37, with oxygen being depleted rapidly at 
high doses. If the oxygen depletion effect is indeed the underlying mechanism of the normal-tissue protection, it 
would be expected that preclinical studies will move towards hypo- or single-fractionated regimen with high doses 
per fraction to increase the therapeutic ratio. Currently, FLASH studies have been performed where total doses up to 
40 Gy have been delivered in a short duration. For in-vivo dose verification, this implies that a dosimeter is required 
which does not suffer from saturation effects and maintains a linear or otherwise predictable behavior in response to 
dose.  Radiation damage can also potentially be an issue for sensitive detectors such as MOSFET, however in most 
cases, the damage threshold for dosimeters is orders of magnitude higher compared to the dose threshold where 
dosimeters start showing saturation and non-linearity.   
 
 
 
 
6 
 
 
 
 2.5 Other Ideal Characteristics 
 
While, the previous few sections were primarily focused on dosimetric aspects unique to FLASH-RT, there are still 
other characteristics that make certain radiation dosimeters ideal for dosimetry. These characteristics go hand in hand 
with the ones discussed previously because they will eventually lead to erroneous measurement of dose and 
subsequently dose-rate. Mainly, an ideal dosimeter should be tissue-equivalent and not perturb the radiation field so 
that it can serve as an accurate surrogate for dose measurement inside the patient. A parameter closely tied to tissue 
equivalence is the energy dependence of the dosimeter. Ideally, a dosimeter that is energy-independent is required, 
because one would want the detector to respond uniformly to irradiation irrespective of the radiation quality.  For 
example, certain non-tissue equivalent detector can over respond when there is significant low energy scatter present 
in the radiation field leading to erroneous measurements. These issues are amplified at small fields and can cause 
significant errors. In general, correction factors for small fields can be divided in two categories: 1) volume averaging, 
2) other non-ideal characteristics.  While volume averaging is a purely geometrical concept and can be minimized by 
using dosimeters which are small in volume, non-ideal characteristics are harder to correct for. The volume averaging 
correction factor on the central axis is within 1-2% if the size of the detector is 1/4th of the diameter of the incoming 
beam38. For example, the  unshielded Stereotactic Field Diode (SFD) diode (0.6 mm diameter) by IBA has a volume 
averaging correction factor of 1.003 for a 5 mm circular beam39. However, the overall correction factor for the diode 
has been typically found  to be < 1 in literature,  which implies that the diode tends to over respond to radiation40. 
This over-response is explained by the presence of high-Z silicon in the diode which offers an increased photoelectric 
absorption coefficient at lower energies.   In FLASH-RT, these non-ideal characteristics can be critical because of the 
use of small fields as discussed above.  
 
 
 
3. Radiation Dosimeters 
 
3.1 Charge Based Dosimeters  
Fig 5) Model for charged based detector response based on Advanced Markus Chamber IC, PTW microDiamond, and 
Isorad Gold (n-type) diode detectors. Dose per pulse dependency of detector response are shown for a) conventional 
beams and b) FLASH beams. Advanced Markus Chamber IC response (charge collection efficiency) was calculated 
for three different bias voltages and the only charge-based detector to be tested in FLASH dose rates41. Model for 
diamond detector response (charge collection efficiency) and diode detector response (sensitivity) were only tested at 
conventional dose rates42,43. 
 
Most charged based dosimeters are based on the principle of creation of ion pairs or charges which can be collected 
and correlated to dose. In Ionization Chambers (IC), the collection of ion-pairs is facilitated by an application of an 
external bias across the electrodes. The voltage applied is typically high enough, such that all liberated charges are 
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collected. However, at high doses per pulse, ion-pairs can recombine before they are swept across the E field and 
collected by the electrodes. This can lead to a decrease in sensitivity with increasing dose per pulse. While ion-
recombination effects can be accounted for at moderate doses per pulse using Boag’s model44, at high dose per pulse 
the model breaks down. However, it should be noted that certain commercial IC chambers, such as the Advanced 
Markus IC by PTW can efficiently collect ions at dose-rates as high as ~ 300 Gy/s and a dose per pulse of ~5 mGy. 
This is sufficient for conventional flattening filter free beams and pencil beam-scanned proton beams.  Nevertheless, 
at high instantaneous dose-rates and doses per pulse typically used in FLASH, a correction factor would be needed to 
correct for ion-recombination. A study performed by Petersson et al41, looked into ion-recombination effects of the 
Advanced Markus IC with their FLASH setup. The authors came up with a model to account for ion-recombination 
and polarity effect for the aforementioned chamber (Figure 5). It can be seen that the ion-collection efficiency has a 
strong dependence on dose per pulse above 1 Gy. With the correction factor applied, they concluded that the chamber 
could be used for FLASH dosimetry. In particular, they were able to measure a dose-per-pulse of 10 Gy. Interestingly, 
FLASH studies conducted with protons have employed ICs for dosimetric verification but without application of any 
correction factor. For example, Patriarca et al18  employed a IC in their proton FLASH setup which used a cyclotron-
based 230 MeV (IBA) proton beam as the radiation source. With cyclotron-based sources, high pulse repetition rates 
of around ~100 MHz can be achieved with pulse duration of around ~ 2ns. In this case, one can assume a 100% duty 
cycle, which drastically reduces the instantaneous dose rate or dose delivered in a pulse. Using Boag’s method44, the 
authors found that the total recombination of ions was around 1% at a maximum mean dose-rate of 80 Gy/s . Another 
study conducted by Beyreuther et al13 used a 224 MeV proton beam at a dose-rate of 100 Gy/s and concluded that the 
pulse duration (~100 ms) was an order of magnitude higher than the ion-collection time for the Advanced Markus 
chamber (~10 us).  
Solid-state detectors such as diamonds and diodes have been used extensively for dosimetry in modern 
radiotherapy techniques due to their high sensitivity and small size. The operation of silicon diodes and diamond 
detectors is similar to IC chambers in that radiation produces electron-hole pairs which can be collected. Essentially, 
they can be thought of as solid-state ICs. Whereas, direct recombination is the dominant process in IC, charge 
recombination in solid state detectors is a more complex process dominated by indirect recombination, because of the 
presence of RG (recombination-generation) centers and impurities that can act as trap centers.  In general, dose-rate 
dependence of solid-state detectors can be modeled as σ~Dr
∆, where σ is the electrical conductivity, Dr represents the 
dose-rate and ∆ is a fitting parameter which describes the dose-rate dependency of the detector45. Multiple studies 
have investigated the dose-rate dependence of diodes and diamonds. Ade et al46 found the fitting parameter ∆ for 
some diamond detectors to decrease by as much as 9% when the dose-rate was increased from 2.25 Gy/min to 3.07 
Gy/min. Interestingly, diamond detectors have been have been reported to show increased or decreased sensitivity 
with increasing dose per pulse depending on their construction i.e. pure crystals, Chemical Vapor Deposition (CVD),  
high-pressure high-temperature HPHT46. While diamond detectors have not been extensively used for ultra-high dose-
rate experiments, a microDiamond detector type 60019 (PTW) was used for one proof-of-concept proton-based 
FLASH study by Patriarca et al18. The sensitivity of the aforementioned diamond detector is shown in Figure 5. 
Recombination in diodes is also a complex physical process; whereas sensitivity of IC  decreases with increasing dose 
per pulse, diodes are known to over respond at high dose per pulse47–49. The physical basis of this dependence is due to 
insufficient number of RG centers available for the excess minority carriers to recombine at high dose-rates and doses 
per pulse. Therefore, a larger fraction of charges is left behind and can be collected by the electrode, leading to 
increased sensitivity of the diode. To the best of our knowledge, no FLASH study has used diodes for dosimetric 
verification. Kinetic modelling of the recombination process in solid-state detectors has been carried out by multiple 
groups and we point the reader towards those references for a deeper understanding42,48–50. 
The time resolution of charged based dosimeters is mainly limited by the ion-drift velocity, mobilities of the 
different charge carriers present and other fundamental parameters such as the transit time (time taken for a charge to 
be completely collected) and minority carrier lifetime etc. For ICs with a typical external bias of 300 V, the temporal 
resolution usually ranges from a few ms to hundreds of ms51. For indirect band gap semiconductors, such as silicon, 
the time-resolution can be on the order of a few ms52. Pure diamond detectors, due to their superior electron and hole 
mobilities, can offer time resolution on the order of a few ns53, whereas most synthetic diamonds ( i.e. CVD based)  
have a minority carrier lifetime of a few us54. Therefore, real-time dose monitoring is indeed possible with diodes, 
diamonds, and IC. However, it should be reiterated that the main limitation for such devices is the change in 
sensitivity, non-linearity, and saturation due to charge recombination at high instantaneous dose-rates relevant in 
FLASH-RT. For pre-clinical FLASH studies, multiple authors19,55 have circumvented this issue by using a Faraday 
cup; a conductive metal cup which accumulates charge when put in the beam’s path. The main advantage of using a 
Faraday cup is that saturation, ion-collection, and recombination effects can be avoided. Additionally, Faraday Cups 
have been used with nano-second time resolution in studies conducted with high energy and highly pulsed charged 
particle beams56–58.  
Typically, measurements performed with charge based detector are point (1D) or planar measurements (2D). 
The advantage of solid-state charge based detectors over gas-filled ICs is that they offer superior spatial resolution 
because of their increased sensitivity to radiation.  For instance, the PTW microDiamond detector, if used in edge-on 
8 
 
configuration (i.e. smallest dimension normal to the incident beam), exhibits a resolution of 1 µm. Another high 
resolution charge-based dosimeter of interest is the silicon single-strip detector (SSD) which has been touted as a 
potential dosimetric tool for Microbeam Radiation Therapy. The SSD was used at the European Synchrotron 
Radiation Facility and has been shown to demonstrate very high spatial resolution (~10 µm resolution) and high 
dynamic range.59 Despite their high spatial resolution, one caveat of typical charge-based dosimeters is their energy 
dependence and tissue non-equivalence. This limits their usefulness in small field dosimetry which can lead to 
erroneous measurement of dose-rate in pre-clinical animal FLASH studies employing small beams.      
 
3.2 Chemical Dosimeters  
 
Certain materials that undergo structural changes, produce radicals, or change color when irradiated can be 
classified as chemical dosimeters. For example, when a solution of ferrous sulfate (Fricke) is irradiated, ferrous ions 
Fe2+are oxidized to ferric ions, Fe3+. The number of ferric ions produced is proportional to dose delivered and can be 
quantified by measuring the optical density of the solution. Fricke dosimeter was used by Hendry et al55 in their study 
on effects of high dose-rate on oxygen concentration. However,  diffusion of ferrous ions over time makes this 
technique sensitive to low dose-rates60. Similar in nature to the Fricke dosimeter, methyl viologen is another tool that 
was used by Favaudon et al29 in their FLASH setup for online monitoring of dose. Dosimetry was performed by 
optical detection of the MV.+ radical at 603 nm. The authors were able to monitor dose synchronously with the 
electron-pulses, but a decay in the MV.+ radical with time (on the scale of a few minutes) was observed that ultimately 
led to loss in absorption; an issue which can play a major role at low dose per pulse/dose-rate conditions. Therefore, 
while, certain chemical dosimeters can provide absolute dosimetry and real-time detection of dose with ~ns 
resolution, the radiation induced species in these materials are generally not stable and can either diffuse spatially 
(Fe3+) or decay with time(MV.+) which makes such setups unsuitable for real-time dose monitoring in FLASH-RT.   
Fortunately, chemical dosimeters that produce stable radiation-induced species are available. One such 
dosimeter is Alanine and has been extensively used in preclinical FLASH studies12,34. Alanine is an amino acid, which 
forms a stable free radical upon irradiation. The concentration of the free radical is proportional to the absorbed dose, 
which can be probed using an electron paramagnetic resonance (EPR) spectrometer.  Alanine dosimeters exhibit a 
linear response over a large dynamic range (2Gy-150kGy) and are therefore routinely used in industrial facilities. 
Although, at doses below 2 Gy, alanine can show considerable relative uncertainty of ~1.5%61 . However, this might 
not be an issue for FLASH dosimetry because generally high doses are needed to elicit the FLASH effect. The real 
value of alanine dosimeters for FLASH dosimetry is in their excellent dose-rate independence (up to ~3 x 1010 
Gy/s62). Recently, alanine was used at the European Synchrotron Radiation Facility (ESRF), which is capable of 
producing really high dose-rates (~ 10kGy/s)63; the response of alanine was found to agree well with the PTW 
PinPoint IC, when the latter was corrected for ion-recombination effects.  
Perhaps the major advantage of certain chemical based detectors in their inherent ability to provide planar or 
3D measurements. One really popular and perhaps the major workhorse of the radiation dosimetry world, is the poly-
diacetylene based self-developing radiochromic film. Upon irradiation, the film undergoes color change by 
polymerization. The change in color is typically quantified in terms of the optical density as measured by a 
densitometer or in some cases via microscopy. Radiochromic films can be considered to be the ideal dosimeter, in that 
they are energy independent, tissue equivalent, and demonstrate really high spatial resolution (sub-micron) limited 
only by the digitizing method. Additionally, dose-rate independence of radiochromic films is well established in 
literature and they have been found to be independent of any dose-rate effects up to a dose-rate of 15x 109 Gy/s64. In 
fact, EBT3 Gafchromic Film (Ashland, Wilmington, DE) was used by Patriarca et al18 to evaluate dose-rate 
independence of other dosimeters used in their FLASH setup. A detailed study was conducted by Jaccard et al65(p3) on 
the suitability of radiochromic film for high dose-rate FLASH dosimetry with the Oriatron eRT6 electron linear 
accelerator (PMB-Alcen, Peynier, France) and they concluded that film was independent up to a Ḋp of 8 x 106 Gy/s. 
Additionally, radiochromic film has been used to measure dose homogeneity and verify field sizes in various different 
FLASH studies9–11  and was also used to verify dose (along with alanine) for the human patient treated with FLASH-
RT. One of the major drawbacks of radiochromic film is that measurements are performed offline, typically 24 hours 
post exposure to account for the fact that polymerization does not stop immediately after irradiation.  In theory, real-
time read-out of film can be performed with ms time resolution, since it has been reported in literature that 
polymerization is largely ‘complete’ within 2 ms of a 50 ns pulse66;  however, as started earlier, polymerization still 
continues post-exposure which can act as a confounding variable for near real-time dosimetry. Nonetheless, attempts 
have been made at real-time readout of radiochromic film67,68.  
Certain chemical dosimeters can provide true 3D spatial dose distribution at high resolution and in patient 
geometry. This has been facilitated by the recent advent of gelatin-based polymers, which avoid the problem of ion 
diffusion encountered in Fricke dosimeters. However, diffusion in polymer gels can still occur in the first hour post 
irradiation and at high dose-gradients and high doses69. Essentially, polymer gels act as 3D radiochromic film, except 
that the change in optical density is probed in 3D as opposed to a single 2D plane. Multiple methods have been used 
to probe these radiation sensitive gels, such as MRI, x-ray CT, ultrasound and optical projection tomography (OPT)69. 
However, OPT has stood out as the more popular read-out method, because of the high spatial resolution it offers. 
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Unfortunately, like all chemical dosimeters, some change in signal is expected with time. Change in signal post-
exposure coupled with the fact that complicated read-out machinery is needed to probe the response to radiation, 
renders this technique unsuitable for real-time dose measurement. More importantly, in FLASH-RT context, polymer 
based gels have been known to show dose-rate dependence, which might be attributable to competing radiation 
induced chemical reactions in the gel and the dose-rate dependence of water radiolysis products70. The dose-rate 
dependence seems to be a function of concentration of oxygen scavengers in the matrix, with less dose-rate 
dependence seen at high concentrations of O2 scavengers71. Dose-rate dependence is also a function of the type of 
monomer unit of the gel70. For a more detailed analysis on the origin of dose-rate dependence in polymer gels, we 
refer the reader to a comprehensive review by De Deene et al70.  
 
 
3.3 Luminescent Dosimeters 
 
In this text, luminescence refers to any technique which utilizes generation of optical photons in response to 
radiation as a surrogate for dose. This generally includes thermoluminescent detectors (TLD), optically stimulated 
luminescence detectors (OSLD), organic/inorganic scintillators and Cherenkov radiation. Physical properties that 
enable luminescent detectors to be of value in FLASH-RT will be discussed.  
 
3.3.1) TLD and OSLD  
 
Figure 6. Luminescence in thermally and optically stimulated luminescent detectors. a)  Irradiation leads to promotion 
of electrons from the valence band to conduction band. Electron and holes are subsequently trapped at trap centers 
which are introduced by doping impurities into crystals. b) An external stimulus in the form of heat or light is then 
provided to facilitate electron-hole recombination at luminescent center, which leads to production of optical photons. 
  
When impurities are added to certain crystals, charge trapping occurs due to the added energy levels in the 
conduction-valence band gap. These additional energy levels act as traps for electrons and holes. Application of an 
external stimulus allows the trapped electrons and holes to escape allowing recombination at luminescent centers. It is 
this recombination process which leads to luminescence (Figure 6). Depending on the external stimulus, the 
dosimeters can be classified as TLD (thermo-luminescent dosimeter) or OSLD (optically stimulated luminescent 
dosimeter). The luminescence is considered to be delayed because the electrons and holes can remain trapped over 
long periods of time (sometimes up to thousands of years) and can only be read-out after stimulation. The practical 
implication of this is that real-time dosimetry is not feasible using TLD or OSLDs.  In some cases however, certain 
materials such as europium-doped alkali halides, may exhibit short trap emptying (~25 ms) and luminescent decay 
times (~1 μs) which may render real-time dose monitoring possible72.  
Despite the lack of real-time readout, TLDs and OSLDs are of great importance in high dose-rate dosimetry 
because of their excellent dose-rate independence. In fact, one of the earliest studies of dose rate effect on skin 
toxicity in mice (1980) by Inada et al73 used a lithium borate TLD to verify dose. They confirmed the lithium borate 
TLD to be independent up to a dose rate of 1.5 x 109 Gy/s. Dose-rate dependency of TLDs has been investigated by 
multiple authors over the last few decades. Karzmarck et al74 found LiF TLD to be dose-rate independent up to 2 x 
106 Gy/s.  Tochilin and Goldstien 75 found the same TLD to be dose-rate independent up to 1.7 x 108 Gy/s. More 
recently, Karsch et al64 compared dose-rate independence of various detectors including TLDs and OSLDs. They 
found TLD and OSLD to be dose-rate independent up to 4 x 109 Gy/s within 2%. In the context of FLASH, Jorge et 
al34 compared LiF-100 TLD (Thermo Fisher, USA) against two dose-rate independent dosimeters, alanine and 
radiochromic film. The Oriatron eRT6 linac was used for this study with dose-rates ranging from 0.078 Gy/s up to 
1500 Gy/s and the results are presented in Figure 7. Alanine, film, and the LiF-100 TLD were found to agree within 
3% at all dose-rates.  
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Figure 7. Measured absorbed dose under different dose-rate conditions for alanine, film and 
TLD. All detectors were found to agree within 3% at conventional and FLASH dose-rates, 
indicating excellent dose-rate independence34. 
 
In addition to dose-rate independence, TLD can be manufactured to be small and in powdered form. This is 
beneficial for small field dosimetry where high resolution is required. Additionally, the small form factor coupled 
with the ability to read out dose post irradiation renders TLDs as a viable tool for in-vivo dose verification. Indeed, 
for one FLASH study on mice whole brain irradiation15, dosimetric verification was performed in-vivo using  3 x 3 x 
1 mm3 TLD chips embedded inside the brain of a mouse cadaver at different points. A total dose of 10 Gy was either 
delivered in a single 1.8 us pulse or at conventional dose-rates (0.1Gy/s). The placement of the TLDs and the dose 
verification are shown in Figure 8. The dose measured by the TLDs agreed well with the prescribed dose of 10 Gy. 
Additionally, no dose rate effect was seen between measurements performed at 0.1 Gy/s compared to dose delivery in 
a single 1.8 us pulse (5 x 107 G/s).  This was one of the first non-superficial, in-vivo measurements performed at 
FLASH dose-rates.  
 
 
Figure 8.a) The three different positions where the TLDs were placed inside the brain of a mouse cadaver (sagittal/center, lateral 
left and right). b) The measured dose at different points. The black markers represent 10 Gy delivered in a single pulse of 1.8 us 
(FLASH-RT). The light gray markers represent the dose delivered at a dose-rate of 0.1Gy/s (i.e. conventional dose-rate). Error 
bars represent the relative uncertainty in the absorbed dose measurements (+8.2% in each case)15.  
 
One caveat of TLDs and OSLDs is that measurements are usually limited to a point. To overcome this, a few 
investigators have studied the possibility of using planar arrays of TLDs and OSLDs to measure spatial distribution of 
dose. One such TLD array was designed and tested at the European Synchrotron Radiation Facility (ESRF) by 
Ptaszkiewicz et al76.  The study was primarily aimed at Microbeam Radiation Therapy (MRT); a novel external beam 
radiotherapy technique in which quasi-parallel beams with widths around 25-50 μm separated by 100-400 μm are 
delivered at ultra-high dose rates. The results are relevant to FLASH  because dose-rates in MRT can reach up to a 
few kGy/s77. The TLD array consisted of LiF:Mg,Cu,P 10 x 10 x 0.3 mm3 foils with different grain sizes (up to 150 
μm). Dose read-out was performed using a 12-bit CCD camera with sub-millimeter resolution. Therefore, dose-rate 
independence and sub-millimeter resolution make this setup an attractive choice for FLASH-RT. Reusable 2D OSLD 
arrays have also been constructed with submillimeter resolution and large dynamic dose range78,79.  
Another passive luminescent detector of note is the Fluorescent Nuclear Track Detector (FNTD)80. FNTDs 
employ a single crystal of Aluminum Oxide doped with Magnesium and Carbon (Al2O3:C, Mg) with additional 
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oxygen vacancy defects.  The underlying physics is similar to OSLDs but with minor differences. Specifically, 
exposure to radiation produces new recombination or color centers which can then be probed non-destructively using 
microscopy techniques. In contrast, new recombination centers are not formed in OSLDs when exposed to radiation. 
This technique has been used for dosimetry in MRT81 where spatial resolution of 1 μm was achieved. Additionally, 
FNTDs have also been tested to be dose-rate independent up to 108 Gy/s and are capable of measuring dose over a 
large dynamic range ( 3 mGy to 100 Gy)80. Therefore, FNTDs are an attractive choice for dosimetry in FLASH-RT.  
 
 
3.3.2) Scintillators  
 
 
Figure 9. Typical processes of scintillation in a) organic and b) inorganic scintillators. The time scales over which 
these processes occur are also shown, indicating excellent temporal resolution. Figure b) was adapted from Nikl et al82 
 
Scintillation is the phenomena by which an interaction of certain material (scintillator) with high energy photon or 
charged particle results in emission of optical photons. Scintillators can be broadly divided into two different 
categories 1) organic and 2) inorganic83,84, with underlying physical mechanisms depicted in Figure 9.  The process of 
scintillation in both material types follows a general mechanism composed of conversion, transport (migration), and 
luminescence. Organic scintillators are typically aromatic hydrocarbon compounds, that produce excited states by 
ionizing radiation, and subsequently luminesce due to allowed π electron transitions between excited singlet state S10 
to various different vibrational sub-levels of the ground singlet state. When electronic transitions occur between 
singlet states, the emission and decay of luminescence is on the order of a few ns. However, most organic solutions do 
not exhibit high scintillation efficiency and are therefore used in conjunction with a solute. In this case, energy 
transfer occurs mainly via solvent-solvent interactions, and ultimately to the solute by dipole-dipole energy transfer85.  
In the case of polar solvent-based scintillators (e.g. quinine solution in water), ions and radicals are formed rather than 
excited states, and therefore ion recombination must occur prior solute excitation86.  
Inorganic scintillators typically consist of single or poly-crystalline materials, often doped with impurities that 
can act as luminescent centers. In the initial conversion phase, a large number of excited electrons and holes is created 
upon interaction of high energy photon or charged particle with the scintillator matrix, followed by thermalization and 
transport of created excited states to a luminescent center. Unlike in OSLD, an external stimulus to facilitate the 
release and recombination of electrons and holes is not needed due to the presence of an allowed transition at 
luminescent centers, and minimal number of charge traps. Similar to organic scintillators, rise and decay times for 
inorganic scintillators can also be on the order of a few ns.  
Owing to their excellent tissue-equivalence and the ability to be miniaturized, multiple investigators have 
recommended the use of organic scintillators for small field dosimetry21,39,87. In particular, organic scintillators, such 
as the commercially available Exradin W1 (Standard Imaging) can be used as reference detectors for small fields 
against which correction factors for other detectors can be derived39. In contrast to organic type, inorganic scintillators 
are usually made with high-Z materials and are therefore not tissue-equivalent; a scenario which need to be accounted 
for in radiation dosimetry. Nonetheless, they have a role to play in FLASH-RT. Fast rise and decay times, radiation 
hardness and high detection efficiency due to increased photoelectric cross section for x-rays, makes inorganic 
scintillators an ideal tool for applications where superior time-resolution is required.  
Typically, measurements performed with scintillators can be either point, planar 2D or 3D measurements. For 
point measurements, the setup usually consists of a small scintillator coupled to an optical fiber and a photodetector. 
Recently, Archer et al88 demonstrated the use of miniature BG400 plastic scintillator (10 μm thick)  coupled to a fiber 
optic and a SiPM for dosimetry at the Imaging and Medical Beam-Line at the Australian Synchrotron with an average 
dose-rate of 4435 Gy/s, resolving beams of 50 μm width.  
In case of planar or 3D measurements, the setup typically consists of a scintillating volume imaged remotely at high 
spatial resolution (sub millimeter) with a CCD or a CMOS camera. The prompt emission of light, coupled with high 
frame-rate imaging capabilities of modern imaging sensors, make this technique suitable for online monitoring of  
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Figure 10. Scintillating sheet imaged dose rates from a proton pencil beam scanning system with modulated beam 
parameters in the treatment plans. a.  Maximum dose rate distribution with 10 mm spot-spacing b. Cumulative dose 
rate histogram for varying minimum spot weight of a treated layer32. 
 
 
machine output and dose delivery under FLASH irradiation conditions. Optical imaging of scintillation using cameras 
during external beam radiotherapy has already been widely implemented 84,89,90. In a recent study91, a time-gated 
intensified CMOS camera was used to image complex stereotactic radiosurgery (SRS) plans at high dose-rates in a 
radioluminescent phantom. The authors were able to resolve complex and highly modulated dose distributions 
spatially and temporally. Due to its high spatio-temporal resolution, optical imaging has also been used for quality 
assurance purposes in pencil beam scanning (PBS) proton therapy; a technique which also utilizes high dose rates (up  
to 200 Gy/s near the Bragg Peak). For example, Vigdor et al92 used a xenon gas scintillator coupled to large PMTs for 
monitoring 2D beam characteristics in real-time for pulsed and pencil beam scanning proton radiotherapy treatments. 
The authors demonstrated a spatial resolution of a few hundred microns. Additionally, they noted that the gas 
scintillator was able to measure up to a dose rate of 350 Gy/s, whereas an ionization chamber started exhibiting ion-
recombination effects at much smaller dose-rates. In another study, Darne et al93,94 used three CMOS cameras to 
image proton pencil beam scanning inside a phantom filled with a liquid scintillator. The authors were able to image 
at 91 frames per second with sub millimeter resolution. More recently, Rahman et al32 were able to resolve spatio-
temporal (10 ms and 1 mm resolution) dose-rate dynamics up to 26 Gy/s for proton PBS using a scintillating sheet 
and a CMOS camera. As shown in Figure 10, the imaging technique visualized the proton beam parameters that 
modulated dose rate distributions and introduced cumulative dose rate histograms that can potentially be used for 
optimizing dose rate distributions for patient planning in FLASH-RT. One FLASH study by Favaudon et al29, used a 
2D scintillating array coupled to a CCD camera ( Lynx ® , IBA) for monitoring beam profiles. The scintillating 
screen was a 0.5 mm thick gadolinium based plastic material with an active area of 300 x 300 mm2 and a spatial 
resolution of 0.5 mm. The detector was primarily used to assess field size, field homogeneity and dose linearity of the 
system and exhibited excellent linearity with increasing dose. The field homogeneity and FWHM values measured by 
the scintillating detector were within 1% at high and low dose rates. Peak dose-rate used in the study was around 2.4-
3.5 x 106 Gy/s.  The Lynx ®  detector was also used by Beyreuther et al13 for measuring field homogeneity in their 
proton FLASH setup. Multiple investigators have now used cameras and scintillation to reconstruct dose in 3D95–98. In 
the context of FLASH, this implies that a dose-rate independent detector that can measure dose in 3D with high 
spatial and temporal resolution ought to be able to measure dose-rate distribution in 3D in real-time. This information 
can potentially be used to predict the spatial distribution of the protective effect of FLASH in patient geometry.  
 
 
 
 
 
 
 
 
 
 
 
 
 
13 
 
 
3.3.3) Cherenkov Radiation  
 
Figure 11. a) Huygens representation of Cherenkov radiation mechanism in dielectric medium. Light is generated in 
a cone at caustic angle θc around the trajectory of charged particle. b) Energy dependence of Cherenkov radiation for 
different materials (adapted from Glaser et al99). 
 
Cherenkov radiation is the emission of optical photons in a dielectric medium when a charged particle travels 
at a phase velocity that exceeds the phase velocity of light in the medium. Electromagnetic fields associated with a 
charged particle can polarize the medium. If the particle moves slowly (relative to the speed of light in the medium), 
the relaxing dipoles experience a net destructive interference, and no light is emitted. However, if the particle’s phase 
velocity exceeds that of light, asymmetric polarization can occur along the particle’s trajectory, and the relaxing 
dipoles radiate energy with a net constructive interference, observed as visible Cherenkov radiation  (Figure 11a). In 
contrast to scintillation, the Cherenkov light is not emitted isotropically, but rather in a cone with its axis aligned with 
particle trajectory. It has been shown by multiple groups that above the threshold for Cherenkov (261 keV in water) 
generation, the intensity of light emitted is proportional to dose99–101, albeit with prominent energy dependence for 
particles below ~1 MeV. Importantly, Cherenkov light is created instantaneously102 (~10-12 s) upon interaction of the 
charged particle with the dielectric medium; this is faster than what most scintillators are capable of because of the 
various non-radiative mechanisms specific to the process of scintillation. Multiple investigators have now made use of 
Cherenkov radiation as time-of-flight PET detectors102–104 due to its fast time response. Cherenkov radiation has also 
found use in pulse radiolysis studies with pico105 and femtosecond106 time resolution. Additionally, Cherenkov 
radiation has been imaged in real-time107(p),108 during multiple clinical radiotherapy treatments.  The prompt nature of 
light emission, along with dose linearity makes Cherenkov emission an ideal tool for real-time dose monitoring. The 
general experimental setup for Cherenkov based dosimetric imaging is similar to the ones discussed earlier for 
scintillation dosimetry;  an undoped optical fiber (i.e. production of Cherenkov and no scintillation) coupled to a 
photodetector or a volume capable of producing Cherenkov radiation imaged remotely with a camera. In the latter 
case, if a water phantom is subjected to radiation, Cherenkov emission can then be considered to be a water-
equivalent dosimeter. However, due to inherent threshold below which no Cherenkov photons are generated, 
Cherenkov based detectors are expected to be energy dependent; a scenario which is not ideal for radiation dosimetry 
(Figure 11b).  
 In the context of FLASH, a Cherenkov probe was used for online monitoring of dose by Favaudon et al29. A 
number of tests were performed to confirm the efficacy of the Cherenkov detector. In one of the tests, a single 1 μs 
pulse of 3.9 or 5.0 MeV electrons were delivered to the probe. The area under the signal detected by the PMT (voltage 
against time) was found to be proportional to the energy of the beam. In another test, single pulses were delivered 
with increasing pulse widths (0.1 to 2.2 μs), which essentially translates into changing dose. The authors noted that 
the integral Cherenkov emission increased with beam energy, pulse duration and dose, without any saturation effects. 
Based on these results, the authors concluded that Cherenkov radiation has potential to be a useful tool for online-dose 
monitoring under high and low dose-rate conditions.  
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4. Biological Effects and Dosimetry: OER and LET 
 
Figure 12 a) Radiosensitivity and cell surviving fraction dependency on oxygen concentration for FLASH and 
conventional (CONV) radiation therapy. Models are from Pratx et al and Adrien et al for normoxic (20% oxygen 
concentration) and hypoxic (5% oxygen concentration) cells.  b) Oxygen enhancement ratio with 𝑂2  concentration for 
irradiation with different LET 37,109–111 
 
A complete overview of the radiobiological underpinning of the FLASH effect is outside the scope of this 
study. However, the role of oxygen depletion will be briefly discussed here, since it is considered to be one of the 
major factors mediating the FLASH effect. Presence of molecular oxygen is known to make cells more susceptible to 
damage by radiation, as shown in the radiosensitivity curve in Figure 12a. This can be defined in terms of the oxygen 
enhancement ratio (OER), which is the ratio of dose needed to achieve the same biological effect under hypoxic and 
normoxic conditions.  At ultra-high dose rates, it is hypothesized that transient hypoxia occurs which confers a 
protective effect on normal tissue. The improved differential response between tumor and normal tissue arises 
because the microenvironment surrounding solid tumors is already hypoxic112 and remains largely unaffected by the 
depletion of oxygen. The time-scales over which oxygen depletion and reoxygenation occurs is important, since the 
underlying assumption is that oxygen is depleted at a rate faster than it can diffuse back into the normal tissue. Adrian 
et al109 in vitro study supports the model and their results indicated there was no difference between cell death in 
hypoxic (5% oxygen concentration) cells, however cells under normoxic (20% oxygen concentration) oxygen 
conditions, showed increased survival from FLASH compared to conventional irradiation109. This can be attributed to 
larger gradient in radiosensitivity at normoxic oxygen concentration, thus a more prominent FLASH effect. 
 Luminescence imaging, in addition to dose and dose rate, can measure oxygen concentration and play an 
important role in testing the hypothesis in vivo. There are many indirect methods of estimating oxygen concentration 
in tissue including quantifying vascular parameters (intercapillary distance, distance from tumor cells to nearest 
vessel), perfusion, gene expression, protein levels, metabolism, DNA damage113. However, there are only a few direct 
methods of measuring oxygen concentration or tension directly, including the standard procedure of using a 
polarographic needle electrode system114–117. Collingridge et al118 compared the standard polarographic method to an 
oxygen sensing system based on a time-resolved luminescence optical probe. The method relied on measuring the 
lifetime of the luminescence molecules from oxygen-quenching in the tip of the optical fiber and relating it to oxygen 
concentration. The authors confirmed that the time-resolved luminescence probe had the same degree of accuracy as a 
polarographic electrode system in measuring oxygen concentration. However, probes are invasive, measure at single 
points, and are scanned across the tissue to provide a histogram of oxygen concentration. Imaging techniques provide 
methods of quantifying oxygen concentration distributions. Positron emission tomography (PET) with F18 labelled 
markers has been used to image hypoxia, but scans may take 2-4 hours, which is much longer than the time scale of 
FLASH effects113. Alternatively, F19 based oximetry and magnetic resonance imaging can provide oxygen 
concentration at the multiple pixel level119. Electron paramagnetic resonance spectroscopy and imaging with oxygen 
sensitive particulate or water-soluble probes can also provide direct measurement of pO2 or [O2] with sub-millimeter 
spatial resolution and temporal resolution <<1s120,121. More recently, Cherenkov excited luminescent imaging (CELI) 
provided in vivo oxygen pressure maps based on lifetime imaging of  fluorophore platinum(II)-G4 (PtG4)122,123. The 
Stern-Volmer equation was used to relate the decay of PtG4 to oxygen tension in tumors and normal tissue (pre and 
post euthanasia) (Figure 13). The imaging technique achieved submillimeter resolution of 𝑝𝑂2  across the surface and 
near sub-surface of tissue and can potentially image 𝑝𝑂2 post irradiation from a FLASH beam. This could be used to 
help relate the dose rate distribution to the oxygen depletion distribution in the tissue and effects on the OER. 
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 The ability of certain luminescent based detectors to quantify linear energy transfer (LET) can also play a 
crucial role for FLASH-RT.  The OER is dependent on particle type and LET as shown in Figure 12b110. Heavy 
charged particles such as protons and alpha particles can have higher LET than photons or electrons and can reduce 
the effects of the OER. Thus, the oxygen depletion hypothesis brings into question whether heavy charged particles 
will provide the same degree of FLASH effects as electrons and photon FLASH beams. Furthermore, LET 
distribution of heavy charged particles are not homogeneous and have a drastic increase at the Bragg peak of the 
beam. So, quantifying spatial distribution of the LET may be important in describing the differences in FLASH 
effects of heavy particles and photons/electron beams. Currently, Monte Carlo methods or analytical methods are 
often used to determine LET distribution for treatment plans124,125. However, only certain detectors can measure LET 
of charged particle beams and majority of them are based on luminescent techniques. Fluorescence nuclear track 
detectors (FNTD) have been used to measure LET of individual proton tracks.80,126. However, FNTDs have a limited 
range of LET it can detect (5MeV/mm-1000MeV/mm), which does not include the range of LET distribution of 
proton beams. Alternatively, OSLD/TLD response dependency on LET can be utilized to determine both LET and 
dose distribution127,128. Nonetheless, these methods are passive and do not quantify dose or LET distribution in real 
time. Alsanea et al129 showed that variable LET scintillation quenching in two different tissue equivalent organic 
scintillators can be utilized to determine dose and LET distribution in real time129. This method relies on Birk's law of 
scintillation quenching, requires a large difference in the quenching parameter, and requires the scintillators to be 
made of the same material (i.e. electron density). To note, silicon detectors have also been used to determine the mean 
LET of the proton and show its dependency on clinical proton beam energies (1-194MeV)130. 
 
 
 
 
 
 
Figure 13. Cherenkov excited luminescence imaging of oxygen concentration; a) Schematic of a 6MV x-ray 
beam from the linear accelerator used to excite luminescence and captured by a time-synchronized camera; b) 
Time signatures of the x-ray pulse and the imaged luminescence in hypoxic and normoxic tissue; c) Relation 
between 𝑝𝑂2 pressure and luminescent lifetime based on Stern-Volmer model; d) 𝑝𝑂2 map of muscle and 
tumor tissue with their respective histograms shown in e). 123,131,132 
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4. Discussion and Conclusion 
 
 
Figure 14. Dosimeter features relevant to FLASH-RT plotted as spider web plots for the three different categories of 
detectors/tools, including: a) charge-based dosimetry, b) chemical dosimetry/actinometry, and c) optical-based 
dosimetry.  
 
A comprehensive list of dosimeters used in FLASH studies and other high dose-rate modalities is given in 
Table 2. The different columns represent some of the major issues identified in section 2. The values are based on 
typical values and usage encountered in literature. Exception to these values do exist; for example, radiochromic film 
is categorized as a passive detector, but attempts are real-time dosimetry with film has been made in the past67,68. The 
‘Measurement Type’ column has bold entries in it, which indicate the way those dosimeters were employed in 
FLASH-RT studies. The time resolution values are based on the underlying physics of the dosimeters, as explained 
previously. This does not take in to account the available bandwidth of the read-out method. Of course, the dead-time 
of the read-out electronics should be considered while dealing with such dose-rates. While some of these issues are 
not necessarily unique to FLASH-RT, they nonetheless contribute to the overall dosimetric uncertainty.  
Based on the unique temporal beam characteristics of FLASH-RT, dose-rate dependence, spatial resolution (in 
particular, accurate measurement of spatial distribution of dose-rate in a broad-beam), and time-resolution parameters 
shall be emphasized. To compare detectors based on these parameters (and the number of dimensions it has measured 
up to in literature), a spider chart in presented in Figure 14, where a), b) and c) refer to the three different categories of 
detectors. It can be seen that all luminescence based dosimeters exhibit excellent dose-rate independence. For 
chemical dosimeters, radiochromic film and alanine dosimeters also show dose-rate independence up to 109 Gy/s. 
Even though methyl viologen is shown to be dose-rate independent up to a high dose-rate in Figure 14, they tend to be 
dose-rate dependent at really low dose-rates or low doses per pulse conditions because of the diffusion/decay of 
radiation induced species with time. Therefore, such chemical dosimeters, while promising at high dose-rates, might 
not be suitable if they are to quantify an in-homogenous distribution of dose-rate. Charged based dosimeters tend to 
have a complex dependence on dose rate and are highly dependent on the temporal characteristics of the beam.  
For measurement of dose in real-time, it can be seen that, luminescent detectors again tend to be superior 
when compared to chemical and charge based detectors.  Most scintillator based detectors provide ~ns resolution, 
whereas Cherenkov radiation in this regard provides the best theoretical time-resolution (~ps); a fact which makes it 
an ideal candidate for online-monitoring of machine output without suffering from issues such as saturation or dose-
rate dependence. Based on results presented by Favaudon et al29, it can be argued that Cherenkov detectors can play a 
role similar to that of monitor chambers in conventional radiotherapy. Other luminescent detectors, such as 
TLD/OSLD and FNTD are suitable for passive measurements. Nonetheless, they still have a role to play in FLASH-
RT, because of their dose-rate independence.  Most charge-based dosimeters also offer decent temporal resolution; 
however, they are limited by their dependence on dose per pulse/dose-rate. Chemical based dosimeters tend to be 
feasible only for offline measurements, due to cumbersome read-out methods and the general instability (temporal 
and spatial) of radiation induced species. 
Due to an increase in use of small radiation fields, detectors have been miniaturized to the extent, such that a 
resolution of ~1 mm is achievable with most modern detectors. It is important to distinguish between spatial 
resolution of point detectors from that of imaging detectors. For point detector, the spatial resolution is defined in 
terms of the spatial extent of the sensitive volume. For imaging detectors, the inter-detector spacing is perhaps a more 
suitable measure of spatial resolution. While, point solid state detectors, such as diamonds and diodes can indeed be 
constructed to be small, imaging arrays based on these detectors typically tend to exhibit an inter-detector spacing of 
3-5 mm. Dose-rate dependence coupled with sparse detector spacing, makes these imaging arrays unsuitable for 
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FLASH purposes. Additionally, solid-state devices tend to be non-tissue equivalent and energy dependent which can 
further complicate dosimetry due to small field issues. Comparing chemical and luminescent detectors, it can be seen 
that radiochromic film provide the best possible spatial resolution. High spatial resolution, tissue equivalence and 
dose-rate independence make radiochromic films an ideal tool for measuring spatial distribution of dose-rate in 
FLASH-RT. However, luminescent based detectors based on optical imaging techniques can provide the 
aforementioned qualities of radiochromic film, with the added advantage of high temporal resolution which makes 
real-time dose monitoring possible. 
In addition to traditional dosimetry, the bio-chemical dose response of FLASH-RT was also discussed. In 
particular, it was shown that luminescent techniques can sense oxygen tension in real-time and can also measure dose 
and LET simultaneously for particle therapy. These parameters are crucial to understanding the underlying 
radiobiological mechanisms of the protective effect of FLASH. Questions such as how the FLASH effect varies with 
LET, oxygen concentration etc. can be answered using these techniques. In conclusion luminescence was presented as 
a tool which can play a diverse role in the performing dosimetry and understanding the FLASH effect caused by ultra-
high dose-rates.  
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Response Detectors 
Instantaneous Dose-
Rate/ 
Dose per Pulse 
(Dp) Dependence 
 
Spatial 
Resolution 
 
Time- 
Resolution 
Energy 
Dependence 
Measurement 
Type 
FLASH Study 
Luminescence 
TLD/OSLD 
Independent 
(~109 Gy/s)74,133 
~ 1 mm Passive 
Tissue-
equivalent 
1D, 2D e15,34,65 
Scintillators 
Independent 
(~106 Gy/s)29 
~ 1 mm ~ns 
Tissue-
equivalent 
1D,2D,3D p13,18 
Cherenkov 
Independent 
(~106 Gy/s)29 
~ 1 mm ~ps 
Energy 
Dependent 
1D,2D,3D 
 
e29 
FNTD 
Independent 
(~108 Gy/s)80 
~ 1 μm Passive 
Energy 
Dependent 
2D NA 
Charge 
Ionization 
Chambers 
Dependent on Dp41,46 
(>1 Gy/pulse) 
~3-5 mm ~ms 
Energy 
Dependence 
shows up > 2 
MeV 
1D,2D 
p13,18,19 e15,34,65 
ph16,17 
Diamonds 
Dependent on Dp 
(>1 mGy/pulse)42 
~ 1 mm ~μs 
Tissue-
equivalent 
1D p18 
Si Diode 
Dependent on Dp48 
(Independent ~0.2 
Gy/s)134 
~ 1 mm ~ms 
Energy 
Dependent 
1D,2D NA 
Chemical 
Alanine Pellets 
Independent 
(108 Gy/s)63 
~ 5 mm Passive 
Tissue-
equivalent 
1D e12,15,34,135 
Methyl Viologen/ 
Fricke 
Depends on the decay 
rate and diffusion of 
radiation induced species 
~ 2 mm ~ns 
Tissue-
equivalent 
1D e29,41 
Radiochromic 
Film 
Independent 
(109 Gy/s)64,65 
~1 μm Passive 
Tissue-
equivalent 
2D 
p18,19 
e10–
12,15,30,34,65,136 
ph16 
Gel Dosimeters 
Strong dependence below 
0.001 Gy/s137 and above 
0.10 Gy/s138 
~1 mm Passive 
Tissue-
equivalent 
3D NA 
Table 1.  Dosimeters and their capabilities rated for potential FLASH-RT dose measurement of key parameters.  
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